CD91:XETRA:XETRA-Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing (EUR)

ETF | Others |

Last Closing

USD 27.105

Change

0.00 (0.00)%

Market Cap

USD 0.28B

Volume

9.31K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.05 (-0.10%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.07%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.09 (-0.32%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.07 (+0.23%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.08 (-0.32%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.29 (-0.62%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.82 (+0.58%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.03 (-0.06%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.59 (+0.56%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.26 (+0.53%)

USD 80.38B

ETFs Containing CD91:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.45% 93% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.45% 93% A 92% A
Trailing 12 Months  
Capital Gain 29.84% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.84% 84% B 83% B
Trailing 5 Years  
Capital Gain 27.91% 56% F 60% D-
Dividend Return 4.39% 21% F 17% F
Total Return 32.30% 56% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 1.98% 33% F 34% F
Dividend Return 2.22% 34% F 35% F
Total Return 0.24% 29% F 18% F
Risk Return Profile  
Volatility (Standard Deviation) 17.74% 25% F 38% F
Risk Adjusted Return 12.51% 27% F 30% F
Market Capitalization 0.28B 53% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.